We are live on
!
Find out more
ANI Pharmaceuticals
ANIP
ANIP
173 hedge funds and large institutions have $424M invested in ANI Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 66 increasing their positions, 53 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
28% more call options, than puts
Call options by funds: $2.93M | Put options by funds: $2.3M
25% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 53
2.46% more ownership
Funds ownership: 60.99% → 63.45% (+2.5%)
6% less funds holding
Funds holding: 184 → 173 (-11)
12% less capital invested
Capital invested by funds: $480M → $424M (-$56.5M)
32% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 28
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
173
Holders Change
-11
Holders Change %
-5.98%
% of All Funds
3.96%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
19
Increased
66
Reduced
53
Closed
28
Calls
$2.93M
Puts
$2.3M
Net Calls
+$638K
Net Calls Change
-$4.23M
Top Buyers
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$7.07M |
| 2 |
First Manhattan
New York
|
+$4.28M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$3.52M |
| 4 |
PFC
Phocas Financial Corp
Alameda,
California
|
+$3.37M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$3.28M |
Top Sellers
| 1 |
AIA
Avalon Investment & Advisory
Houston,
Texas
|
-$3.22M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
-$3.14M |
| 3 |
Morgan Stanley
New York
|
-$2.53M |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$2.03M |
| 5 |
MSL
Mackay Shields LLC
New York
|
-$1.95M |
